Management of in-stent CTO
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be...Read More
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be expressed more clearly. We believe that learning is quicker, with more information being retained when it is presented in the correct way.
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex...
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.